USPTO serial 85860190
CELSUS THERAPEUTICS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- GOODMAN, WENDY BETH
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CELSUS THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products and preparations for treating disease, namely, obstructive respiratory disease, asthma, inflammatory and anti-viral diseases, colitis, Crohn's disease, central nervous system insult, multiple sclerosis, contact dermatitis, psoriasis, cardiovascular disease, invasive cellular proliferative disorders, allergic rhinitis, cystic fibrosis, inflammatory disease of the skin, ophthalmologic diseases, hemolytic syndromes, sepsis, acute respiratory distress syndrome, tissue transplant rejection syndromes, autoimmune disease, viral infection, osteoarthritis and hypersensitivity conjunctivitis; pharmaceuticals for use as a coating for cardiovascular stents and other stents; coating treatments, namely, pharmaceutical preparations used to coat devices for the prevention of inflammatory reactions as a result of invasive procedures; anti-oxidants supplements; pharmaceutical preparations, namely, anti-inflammatories and analgesics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Celsus Therapeutics Plc
- Other trademarks owned by Morria Biopharmaceuticals Plc
- Other trademarks owned by Morria Biopharmaceuticals Plc
- Other trademarks in Class 005
- Similar marks named CELSUS THERAPEUTICS
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 2, 2015 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 2, 2015 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 1, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 31, 2015 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 24, 2015 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 24, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 2, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 1, 2014 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 29, 2014 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 29, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 2, 2014 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 1, 2014 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 28, 2014 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 3, 2014 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 3, 2014 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 2, 2013 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Oct 1, 2013 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 24, 2013 | APET | ASSIGNED TO PETITION STAFF | — |
| Sep 9, 2013 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Aug 28, 2013 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Aug 6, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 6, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 17, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 1, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 26, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jun 10, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 10, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 10, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 10, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 4, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 1, 2013 | NWAP | NEW APPLICATION ENTERED | — |